TORNTPHARM — Torrent Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹859.45bn
- IN₹894.90bn
- IN₹96.20bn
- 92
- 11
- 93
- 78
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11,635 | 6,623 | 7,380 | 5,830 | 7,228 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,846 | 19,957 | 18,956 | 19,216 | 22,371 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 50,375 | 49,809 | 55,232 | 52,947 | 53,292 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 32,800 | 35,299 | 36,288 | 32,469 | 34,598 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 141,209 | 140,097 | 140,747 | 130,998 | 150,119 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 51,653 | 54,542 | 48,916 | 44,151 | 54,473 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 93,966 | 91,865 | 82,375 | 71,469 | 88,138 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 47,244 | 48,232 | 58,372 | 59,530 | 61,981 |
Total Liabilities & Shareholders' Equity | 141,209 | 140,097 | 140,747 | 130,998 | 150,119 |
Total Common Shares Outstanding |